Roche Applied Science Revenue Rises 8 Percent in H1 on Strong Array, Sequencer Sales

Roche attributed the increase to the launch of more applications on NimbleGen's 2.1-million feature HD2 array platform and the introduction of a complete microarray workflow.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.